122 related articles for article (PubMed ID: 3179935)
21. [Clinicopathological evaluation on ovarian serous borderline tumours and their implants].
Guo L; Lian L; Liu T
Zhonghua Fu Chan Ke Za Zhi; 1996 May; 31(5):287-90. PubMed ID: 9206182
[TBL] [Abstract][Full Text] [Related]
22. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
Zuna RE; Behrens A
J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
[TBL] [Abstract][Full Text] [Related]
23. Classification of Extraovarian Implants in Patients With Ovarian Serous Borderline Tumors (Tumors of Low Malignant Potential) Based on Clinical Outcome.
McKenney JK; Gilks CB; Kalloger S; Longacre TA
Am J Surg Pathol; 2016 Sep; 40(9):1155-64. PubMed ID: 27428735
[TBL] [Abstract][Full Text] [Related]
24. Serous psammocarcinoma of the ovary and peritoneum.
Gilks CB; Bell DA; Scully RE
Int J Gynecol Pathol; 1990; 9(2):110-21. PubMed ID: 2332269
[TBL] [Abstract][Full Text] [Related]
25. Serous borderline tumors of the peritoneum.
Bell DA; Scully RE
Am J Surg Pathol; 1990 Mar; 14(3):230-9. PubMed ID: 2305929
[TBL] [Abstract][Full Text] [Related]
26. Serous ovarian tumors of low malignant potential with peritoneal implants.
Gershenson DM; Silva EG
Cancer; 1990 Feb; 65(3):578-85. PubMed ID: 2297647
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic factors and treatment for advanced-stage borderline ovarian tumors].
Morice P; Camatte S; Rouzier R; Pautier P; Atallah D; Pomel C; Lhomme C; Duvillard P; Castaigne D
J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7):623-8. PubMed ID: 12457134
[TBL] [Abstract][Full Text] [Related]
28. Ovarian serous cystadenofibromas associated with a low-grade serous carcinoma of the peritoneum.
Hinson SA; Silva EG; Pinto K
Ann Diagn Pathol; 2013 Jun; 17(3):302-4. PubMed ID: 22921726
[TBL] [Abstract][Full Text] [Related]
29. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N
Gynecol Oncol; 2007 Jul; 106(1):44-51. PubMed ID: 17467045
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
[TBL] [Abstract][Full Text] [Related]
31. Borderline tumors of the ovary and peritoneal implants.
Denkert C; Dietel M
Verh Dtsch Ges Pathol; 2005; 89():84-91. PubMed ID: 18035677
[TBL] [Abstract][Full Text] [Related]
32. Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome.
Sneige N; Thomison JB; Malpica A; Gong Y; Ensor J; Silva EG
Cancer Cytopathol; 2012 Aug; 120(4):238-44. PubMed ID: 22826172
[TBL] [Abstract][Full Text] [Related]
33. [The 2016 update of the S3 guideline for malignant tumours of the ovary : Role of pathology in diagnosis, therapy and clinical management of epithelial tumours].
Staebler A; Mayr D
Pathologe; 2017 Jul; 38(4):331-344. PubMed ID: 28664411
[TBL] [Abstract][Full Text] [Related]
34. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
Kennedy AW; Hart WR
Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
[TBL] [Abstract][Full Text] [Related]
35. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
[TBL] [Abstract][Full Text] [Related]
36. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
37. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
38. Prognosis for advanced-stage primary peritoneal serous papillary carcinoma and serous ovarian cancer in Taiwan.
Chao KC; Chen YJ; Juang CM; Lau HY; Wen KC; Sung PL; Fang FY; Twu NF; Yen MS
Taiwan J Obstet Gynecol; 2013 Mar; 52(1):81-4. PubMed ID: 23548224
[TBL] [Abstract][Full Text] [Related]
39. Invasive and noninvasive implants in ovarian serous tumors of low malignant potential.
Michael H; Roth LM
Cancer; 1986 Mar; 57(6):1240-7. PubMed ID: 2417697
[TBL] [Abstract][Full Text] [Related]
40. The presence and location of epithelial implants and implants with epithelial proliferation may predict a higher risk of recurrence in serous borderline ovarian tumors: a clinicopathologic study of 188 cases.
Quddus MR; Sung CJ; Zhang C; Moore RG; Ou JJ; Steinhoff MM; Lawrence WD
Hum Pathol; 2012 May; 43(5):747-52. PubMed ID: 22047646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
